WO2002009763A3 - Transdermal drug delivery system - Google Patents
Transdermal drug delivery system Download PDFInfo
- Publication number
- WO2002009763A3 WO2002009763A3 PCT/IL2001/000630 IL0100630W WO0209763A3 WO 2002009763 A3 WO2002009763 A3 WO 2002009763A3 IL 0100630 W IL0100630 W IL 0100630W WO 0209763 A3 WO0209763 A3 WO 0209763A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- delivery system
- drug delivery
- transdermal drug
- pyretic
- analgesic
- Prior art date
Links
- 238000013271 transdermal drug delivery Methods 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 abstract 2
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 2
- 230000001754 anti-pyretic effect Effects 0.000 abstract 2
- 239000002221 antipyretic Substances 0.000 abstract 2
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002417275A CA2417275A1 (en) | 2000-07-27 | 2001-07-10 | Transdermal drug delivery system |
EP01949852A EP1307231A2 (en) | 2000-07-27 | 2001-07-10 | Transdermal drug delivery system |
AU2001270963A AU2001270963A1 (en) | 2000-07-27 | 2001-07-10 | Transdermal drug delivery system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL137559A IL137559A (en) | 2000-07-27 | 2000-07-27 | Transdermal drug delivery system |
IL137559 | 2000-07-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002009763A2 WO2002009763A2 (en) | 2002-02-07 |
WO2002009763A3 true WO2002009763A3 (en) | 2002-04-18 |
Family
ID=11074457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2001/000630 WO2002009763A2 (en) | 2000-07-27 | 2001-07-10 | Transdermal drug delivery system |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030170296A1 (en) |
EP (1) | EP1307231A2 (en) |
AU (1) | AU2001270963A1 (en) |
CA (1) | CA2417275A1 (en) |
IL (1) | IL137559A (en) |
WO (1) | WO2002009763A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004000358A1 (en) * | 2002-06-20 | 2003-12-31 | Amnon Sintov | Transdermal drug delivery system |
ES2535045T3 (en) | 2003-04-10 | 2015-05-04 | Vanderbilt Royalty Sub L.P. | Uses and compositions for capsaicin administration |
US8157788B2 (en) * | 2003-11-06 | 2012-04-17 | Paolo L. Manfredi | Multi-site drug delivery platform |
AU2005244096B2 (en) * | 2004-05-07 | 2011-03-17 | Algenis Spa | Transdermal administration of phycotoxins |
US8252319B2 (en) | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
ATE471146T1 (en) | 2004-10-21 | 2010-07-15 | Durect Corp | TRANSDERMAL DELIVERY SYSTEMS |
DE102005021806A1 (en) * | 2005-05-04 | 2006-11-16 | Lancaster Group Gmbh | Use of radical-scavenging substances for the treatment of conditions with increased skin temperature, in particular for antipyretic treatment |
US20070065494A1 (en) * | 2005-08-03 | 2007-03-22 | Watson Laboratories, Inc. | Formulations and Methods for Enhancing the Transdermal Penetration of a Drug |
JP5542665B2 (en) * | 2007-06-08 | 2014-07-09 | サムヤン バイオファーマシューティカルズ コーポレイション | Matrix-type transdermal administration agent and method for producing the same |
US20090130048A1 (en) * | 2007-11-19 | 2009-05-21 | Oronsky Bryan Todd | Topical Composition for Treating Pain |
US8784872B2 (en) | 2007-11-19 | 2014-07-22 | Comgenrx, Inc. | Formulation for decreasing tobacco, alcohol, drug or food consumption |
WO2009158667A2 (en) * | 2008-06-27 | 2009-12-30 | Comgenrx, Inc. | Povidone compositions for wound healing |
BRPI0914454A2 (en) * | 2008-10-21 | 2015-10-27 | Novodermix Internat Ltd | "composition for the treatment of epithelial tissue" |
IT1397246B1 (en) * | 2009-05-14 | 2013-01-04 | Fidia Farmaceutici | NEW MEDICATIONS FOR TOPIC USE BASED HYALURONIC ACID SULFATED AS AN ACTIVATING OR INHABITING CITHOCINIC ACTIVITY |
WO2023235688A1 (en) | 2022-06-03 | 2023-12-07 | Dow Global Technologies Llc | Formulation for transdermal delivery |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4917886A (en) * | 1982-10-07 | 1990-04-17 | Ciba-Geigy Corporation | Novel topically administrable pharmaceutical compositions |
WO1991016929A1 (en) * | 1990-05-10 | 1991-11-14 | Novo Nordisk A/S | A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
US5314915A (en) * | 1991-09-25 | 1994-05-24 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
WO1997042987A1 (en) * | 1996-05-13 | 1997-11-20 | Ben-Gurion University Of The Negev | Composition and method for forming biodegradable implants in situ and uses of these implants |
WO1998020872A1 (en) * | 1996-11-14 | 1998-05-22 | Halldor Thormar | Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4908389A (en) * | 1986-08-27 | 1990-03-13 | Warner-Lambert Company | Penetration enhancement system |
US5985860A (en) * | 1992-06-03 | 1999-11-16 | Toppo; Frank | System for transdermal delivery of pain relieving substances |
ATE164644T1 (en) * | 1992-07-27 | 1998-04-15 | Procter & Gamble | LAMINATED DOUBLE TEXTURED TREATMENT PADS |
IT1291362B1 (en) * | 1997-05-13 | 1999-01-07 | Vectorpharma Int | BIPHASIC MULTICOMPONENT PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTANCES SUITABLE TO MODIFY THE PARTITION OF THE ACTIVE SUBSTANCES |
US6348212B2 (en) * | 1999-05-18 | 2002-02-19 | Lectec Corporation | Treating traumatic burns or blisters of the skin |
US6645520B2 (en) * | 1999-12-16 | 2003-11-11 | Dermatrends, Inc. | Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
WO2004000358A1 (en) * | 2002-06-20 | 2003-12-31 | Amnon Sintov | Transdermal drug delivery system |
-
2000
- 2000-07-27 IL IL137559A patent/IL137559A/en not_active IP Right Cessation
-
2001
- 2001-07-10 WO PCT/IL2001/000630 patent/WO2002009763A2/en active Application Filing
- 2001-07-10 AU AU2001270963A patent/AU2001270963A1/en not_active Abandoned
- 2001-07-10 EP EP01949852A patent/EP1307231A2/en not_active Withdrawn
- 2001-07-10 CA CA002417275A patent/CA2417275A1/en not_active Abandoned
- 2001-07-10 US US10/343,008 patent/US20030170296A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4917886A (en) * | 1982-10-07 | 1990-04-17 | Ciba-Geigy Corporation | Novel topically administrable pharmaceutical compositions |
WO1991016929A1 (en) * | 1990-05-10 | 1991-11-14 | Novo Nordisk A/S | A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
US5314915A (en) * | 1991-09-25 | 1994-05-24 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
WO1997042987A1 (en) * | 1996-05-13 | 1997-11-20 | Ben-Gurion University Of The Negev | Composition and method for forming biodegradable implants in situ and uses of these implants |
WO1998020872A1 (en) * | 1996-11-14 | 1998-05-22 | Halldor Thormar | Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections |
Also Published As
Publication number | Publication date |
---|---|
CA2417275A1 (en) | 2002-02-07 |
US20030170296A1 (en) | 2003-09-11 |
IL137559A (en) | 2006-12-31 |
AU2001270963A1 (en) | 2002-02-13 |
EP1307231A2 (en) | 2003-05-07 |
WO2002009763A2 (en) | 2002-02-07 |
IL137559A0 (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002241538A1 (en) | Intrasvascular drug delivery device and use therefor | |
HK1048427A1 (en) | Drug delivery device. | |
HK1048428A1 (en) | Ophthalmic drug delivery device. | |
AU2002255235A1 (en) | Inflatable medical device with combination cutting elements and drug delivery conduits | |
AU2001264887A1 (en) | Drug delivery device | |
WO2002009763A3 (en) | Transdermal drug delivery system | |
MXPA03003957A (en) | Transdermal drug delivery system with improved water absorbability and adhesion properties. | |
AU2001277120A1 (en) | Drug delivery and catheter systems, apparatus and processes | |
AU2123200A (en) | Drug delivery device | |
AU4985600A (en) | Drug delivery device | |
AU2003265226A1 (en) | Transdermal drug delivery device, method and use | |
MXPA03005044A (en) | Reversible gelling system for ocular drug delivery. | |
AU3403201A (en) | Drug delivery device and method | |
WO2003084520A3 (en) | Pharmaceutical preparation containing oxycodone and naloxone | |
AU2002363998A1 (en) | Bioadhesive drug delivery system with enhanced gastric retention | |
AU4194799A (en) | Multimolecular devices, drug delivery systems and single-molecule selection | |
HK1049438A1 (en) | Sub-tenon drug delivery. | |
AU2001250924A1 (en) | A drug delivery and monitoring system | |
AU7839900A (en) | Reusable medication delivery device | |
AU2002341959A1 (en) | Drug delivery devices and methods | |
HK1036230A1 (en) | Drug delivery devices. | |
IL159415A0 (en) | Enhanced drug delivery in transdermal systems | |
AU2001238386A1 (en) | Medication delivery devices | |
AU2003234231A1 (en) | New polyarylates for drug delivery and tissue engineering | |
AU2003217531A1 (en) | Ocular drug delivery systems and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2417275 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001949852 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10343008 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001949852 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |